130 related articles for article (PubMed ID: 22607697)
1. Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosis.
Chi G; Manos-Turvey A; O'Connor PD; Johnston JM; Evans GL; Baker EN; Payne RJ; Lott JS; Bulloch EM
Biochemistry; 2012 Jun; 51(24):4868-79. PubMed ID: 22607697
[TBL] [Abstract][Full Text] [Related]
2. Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosis.
Zwahlen J; Kolappan S; Zhou R; Kisker C; Tonge PJ
Biochemistry; 2007 Jan; 46(4):954-64. PubMed ID: 17240979
[TBL] [Abstract][Full Text] [Related]
3. Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).
Manos-Turvey A; Bulloch EM; Rutledge PJ; Baker EN; Lott JS; Payne RJ
ChemMedChem; 2010 Jul; 5(7):1067-79. PubMed ID: 20512795
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site.
Manos-Turvey A; Cergol KM; Salam NK; Bulloch EM; Chi G; Pang A; Britton WJ; West NP; Baker EN; Lott JS; Payne RJ
Org Biomol Chem; 2012 Dec; 10(46):9223-36. PubMed ID: 23108268
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of chorismate-utilising enzymes by 2-amino-4-carboxypyridine and 4-carboxypyridone and 5-carboxypyridone analogues.
Payne RJ; Bulloch EM; Kerbarh O; Abell C
Org Biomol Chem; 2010 Aug; 8(15):3534-42. PubMed ID: 20532401
[TBL] [Abstract][Full Text] [Related]
6. New Chromane-Based Derivatives as Inhibitors of
Pini E; Poli G; Tuccinardi T; Chiarelli LR; Mori M; Gelain A; Costantino L; Villa S; Meneghetti F; Barlocco D
Molecules; 2018 Jun; 23(7):. PubMed ID: 29933627
[TBL] [Abstract][Full Text] [Related]
7. The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase.
Harrison AJ; Yu M; Gårdenborg T; Middleditch M; Ramsay RJ; Baker EN; Lott JS
J Bacteriol; 2006 Sep; 188(17):6081-91. PubMed ID: 16923875
[TBL] [Abstract][Full Text] [Related]
8. Understanding the different activities of highly promiscuous MbtI by computational methods.
Ferrer S; Martí S; Moliner V; Tuñón I; Bertrán J
Phys Chem Chem Phys; 2012 Mar; 14(10):3482-9. PubMed ID: 22307014
[TBL] [Abstract][Full Text] [Related]
9. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
Chiarelli LR; Mori M; Barlocco D; Beretta G; Gelain A; Pini E; Porcino M; Mori G; Stelitano G; Costantino L; Lapillo M; Bonanni D; Poli G; Tuccinardi T; Villa S; Meneghetti F
Eur J Med Chem; 2018 Jul; 155():754-763. PubMed ID: 29940465
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Transition-State Inhibitors of Chorismate Utilizing Enzymes from Bromobenzene cis-1,2-Dihydrodiol.
Zhang XK; Liu F; Fiers WD; Sun WM; Guo J; Liu Z; Aldrich CC
J Org Chem; 2017 Apr; 82(7):3432-3440. PubMed ID: 28282140
[TBL] [Abstract][Full Text] [Related]
11. Shedding X-ray Light on the Role of Magnesium in the Activity of
Mori M; Stelitano G; Gelain A; Pini E; Chiarelli LR; Sammartino JC; Poli G; Tuccinardi T; Beretta G; Porta A; Bellinzoni M; Villa S; Meneghetti F
J Med Chem; 2020 Jul; 63(13):7066-7080. PubMed ID: 32530281
[TBL] [Abstract][Full Text] [Related]
12. Stereocontrolled Synthesis of a Potential Transition-State Inhibitor of the Salicylate Synthase MbtI from Mycobacterium tuberculosis.
Liu Z; Liu F; Aldrich CC
J Org Chem; 2015 Jul; 80(13):6545-52. PubMed ID: 26035083
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.
Vasan M; Neres J; Williams J; Wilson DJ; Teitelbaum AM; Remmel RP; Aldrich CC
ChemMedChem; 2010 Dec; 5(12):2079-87. PubMed ID: 21053346
[TBL] [Abstract][Full Text] [Related]
14. Integration of ligand and structure based approaches for identification of novel MbtI inhibitors in Mycobacterium tuberculosis and molecular dynamics simulation studies.
Maganti L; Grandhi P; Ghoshal N
J Mol Graph Model; 2016 Nov; 70():14-22. PubMed ID: 27639087
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of lumazine synthase from Mycobacterium tuberculosis as a target for rational drug design: binding mode of a new class of purinetrione inhibitors.
Morgunova E; Meining W; Illarionov B; Haase I; Jin G; Bacher A; Cushman M; Fischer M; Ladenstein R
Biochemistry; 2005 Mar; 44(8):2746-58. PubMed ID: 15723519
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 2,5-dihydrochorismate analogues as inhibitors of the chorismate-utilising enzymes.
Payne RJ; Bulloch EM; Toscano MM; Jones MA; Kerbarh O; Abell C
Org Biomol Chem; 2009 Jun; 7(11):2421-9. PubMed ID: 19462053
[TBL] [Abstract][Full Text] [Related]
17. Understanding the key factors that control the inhibition of type II dehydroquinase by (2R)-2-benzyl-3-dehydroquinic acids.
Peón A; Otero JM; Tizón L; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Gago F; Castedo L; González-Bello C
ChemMedChem; 2010 Oct; 5(10):1726-33. PubMed ID: 20815012
[TBL] [Abstract][Full Text] [Related]
18. New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents.
Chiarelli LR; Mori M; Beretta G; Gelain A; Pini E; Sammartino JC; Stelitano G; Barlocco D; Costantino L; Lapillo M; Poli G; Caligiuri I; Rizzolio F; Bellinzoni M; Tuccinardi T; Villa S; Meneghetti F
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):823-828. PubMed ID: 30889995
[TBL] [Abstract][Full Text] [Related]
19. Structure of ACC synthase inactivated by the mechanism-based inhibitor L-vinylglycine.
Capitani G; Tschopp M; Eliot AC; Kirsch JF; Grütter MG
FEBS Lett; 2005 Apr; 579(11):2458-62. PubMed ID: 15848188
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
